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Abstract. The occurrence and distribution of pituitary adenylate cyclase-activating 
polypeptide (PACAP) is summarized in invertebrate species with special attention to annelids, 
mollusks and arthropods in this review. Furthermore, the role of PACAP is highlighted in 
physiological and behavioural processes of oligochaete (Lumbricus), gastropods (Helix, 
Lymnaea), insect (Drosophila) as well as malacostraca (Litopenaeus). Since its discovery 
PACAP has become increasingly recognized for its important and diversified roles in the 
central and peripheral nervous system and in several peripheral organs of a variety of 
vertebrate and invertebrate species. Twenty-six years after its discovery, PACAP is now one 
of the most extensively studied neuropeptides both in invertebrate and vertebrate species. This 
review surveys the importance of PACAP or PACAP-like peptide(s) in invertebrates. The 
relevance of studies on lower vertebrates and invertebrates, which do not have a pituitary 
gland like higher vertebrate, is to contribute to the unraveling of fundamental effects of 
PACAP or PACAP-like peptide(s) and to provide a comparative view. 
 
Introduction 
Pituitary adenylate cyclase-activating polypeptide (PACAP) was isolated first 26 years ago 
from ovine hypothalamic extract on the basis of stimulating cAMP formation in anterior 
pituitary cells (1, 2). Thereafter, it was also discovered that PACAP has wide distribution not 
only in the hypothalamic nuclei, but in the whole central (CNS) and peripheral nervous 
system (PNS) as well as in several peripheral organs. These include endocrine glands, gonads, 
respiratory and urogenital tracts, digestive system, skin, and muscles suggesting a broader 
function of PACAP than only the stimulation of pituitary gland (3-9). PACAP has two 
biologically active isoforms, PACAP-38 (1) and PACAP-27 (2), which share the same N-
terminal amino acids (AA) and are post-translational modifications of a single precursor, the 
preproPACAP (2, 10, 11). In vertebrates the PACAP-38 form is the predominant isoform both 
in brain and peripheral tissues (4, 12, 13). In contrast, in several invertebrate species the 
concentration of PACAP-27 is significantly higher, suggesting its pronounced role (4, 12, 14-
18). The discovery of PACAP was soon followed by identification of its receptors. Two types 
of receptors were characterized according to their relative affinities for PACAP: PAC1-R as 
well as VPAC1 and VPAC2 (4, 19). PAC1-R is specific for PACAP and VPAC1, VPAC2 
receptors are activated by both PACAP and VIP molecules. PACAP receptors are members of 
G-protein coupled receptor family and are unique in the sense that their complex genes are 
able to generate receptor splice variants, which have been reported for all three receptor types 
(20). The possibility of genes being processed differently and thereby generating receptor 
splice variants, could lead to alterations in pharmacology and signal transduction mechanisms 
(21). Expression and distribution of PACAP and its receptors in the CNS and PNS of 
mammals have been described in detail (4). Broad distribution of PACAP and its receptors are 
also observed in non-mammalian vertebrate species such as avians (22-24), reptiles (25, 26), 
amphibians (27-30) and fish (31-34). Widespread occurrence and distribution of PACAP and 
its receptors suggest that the polypeptide exerts pleiotropic physiological functions (3, 4). 
PACAP and its receptors are involved in numerous physiological functions, for example, as 
regulators of metabolism in the nervous, endocrine, cardiovascular, muscular and the immune 
system. The physiological effects of PACAP in vertebrates are discussed by several excellent 
reviews (4, 35, 36). Soon after the discovery of PACAP in vertebrates, the presence of 
PACAP-like peptide(s) is described in the fruit fly (Drosophila melanogaster) body wall 
neuromuscular junction and its possible role in neuronal plasticity as well as in the memory 
storage and retrieval (37, 38). Thereafter, a number of studies have been published showing 
the presence and physiological role of PACAP or PACAP-like peptide(s) in several 
invertebrate species. In this review we summarize data obtained so far on the occurrence, 
distribution and physiology of PACAP-like peptide(s) and its receptors in different 
invertebrates, such as Oligochaetes, Mollusks, Insects as well as Malacostraca. 
 Expression and localization of PACAP 
Oligochaetes 
The distribution of PACAP-like immunoreactivity (PACAP-IR) was studied in the CNS and 
PNS of three oligochaete (Annelida) worms with immunocytochemistry (IHC) (14). Using 
PACAP-27 (n° 88121-5 antibody; (39, 40)) or PACAP-38 antibodies (anti-PACAP-38, 
Peninsula, CA, USA, (14, 39)) immunopositive cells and fibers were observed in cerebral, 
medial and lateral parts of the subesophageal and ventral cord ganglia. In the peripheral 
nervous system, PACAP-IR was found in the enteric nervous system, epidermal sensory cells 
and clitellum (reproductive organ). The distribution pattern of PACAP-IR was similar in all 
three species (Lumbricus terrestris, Eisenia fetida, Lumbricus polyphemus), suggesting a 
common distributional pattern of PACAP-like peptide(s) in Oligochaete.  
The levels of PACAP-27 (n° 88123-3 antibody) and PACAP-38 (n° 88111-3 antibody, (12)) 
isoforms were also measured in the nervous, intestinal, excretory and reproductive systems of 
adult Lumbricus by RIA (15). PACAP-27 and -38 isoforms were detected at significant 
amount in all of the examined tissues however, their distribution was very heterogeneous. For 
example, the amount of PACAP-27 and PACAP-38 ranged between 0.31-17.12 and 0.02-1.51 
ng/mg total protein, respectively. The level of PACAP-27-like immunoreactivity was 
approximately 10 times higher than that of PACAP-38. In comparison, the highest PACAP-38 
level in human is 4.7 ng/mg total protein in the bed nucleus of the stria terminalis (41). These 
results suggest that, in contrast to vertebrates, the dominant isoform of the peptide is PACAP-
27 in Oligochaeta.  
PACAP immunopositive compounds were also observed in early stages (E1) of the 
embryonic development of the earthworm Eisenia using RIA (n° 88111-3 antibody), dot blot 
and IHC (n° 9211-4 antibody, (42)) methods (17). During embryonic development, the level 
of PACAP-like compounds decreased in cocoon fluids, while PACAP-IR cell bodies 
appeared in the developing body wall, prostomium, pharyngeal wall and CNS. Furthermore, it 
was found that the clitellum of sexually mature worms contained significantly higher levels of 
PACAP-IR than other regions of the same animals or the clitellar region of a non-reproducing 
animal (17).  
The presence and distribution of PAC1-R was described in the ventral nerve cord (VNC) of 
the adult Eisenia using IHC and commercial anti-PAC1-R (43). Based on light and electron 
microscopic observations, the exact anatomical positions of labeled structures were 
established suggesting that PACAP mediates the activity of some interneurons, a few small 
motoneurons and certain sensory fibers. High number of PAC1 receptors was found in both 
pre- and postsynaptic membranes in addition to extrasynaptic sites suggesting that PACAP 
acts as a neurotransmitter and neuromodulator in the earthworm nervous system. In early 
embryonic stages the first appearance of PAC1-R-like immunoreactivity was revealed by WB 
and Far WB methods as early as the E2 developmental stage. Immunolabeled CNS neurons 
were seen in the supraesophageal ganglion and distally, in the subesophageal and ventral 
nerve cord ganglia. Ultrastructurally, PAC1-Rs were located mainly on plasma membranes 
and intracellular membranes, especially on cisternae of the endoplasmic reticulum (43, 44). 
The authors conclude that PACAP-like compounds may affect the differentiation of germinal 
layers (at least that of the ectoderm) and of some neurons and they act as signaling molecules 
during earthworm embryonic development.  
 
Gastropods 
IHC, RIA, WB and mass spectrometric (MS) analysis revealed the presence of both the 27 
and 38 AA isoforms of PACAP-like IR elements in CNS, PNS and peripheral organs of 
simple garden snail, Helix pomatia (9, 16) and pond snail, Lymnaea stagnalis (45). PACAP 
containing neurons were present in each ganglion of the CNS but their distribution pattern 
was not homogenous. The majority of PACAP-IR neurons were observed in the areas where 
different peptide containing neurons are located (46). PACAP-like IR was observed in non-
neuronal cells of the salivary gland, perineurinum of the cerebral ganglion located around the 
blood vessel lacunae and in the wall of anterior aorta suggesting that non-neuronal PACAPs 
enter the circulatory system and thus may have humoral functions (8, 16). Using IHC, it was 
shown that PACAP was absent in the muscle itself, but present in nerve fibers innervating the 
columellar, foot, heart and tentacle flexor muscles (9, 16).  
The concentration of PACAP-27-like polypeptide was significantly higher than that of 
PACAP-38, in contrast mammals, where PACAP-38 is the dominant isoform. However, the 
data obtained in Gastropods correspond well those obtained in an Oligochaete species 
(Lumbricus, Eisenia). Interestingly, both IHC and RIA studies revealed different expression 
levels of PACAP in active and non-active (hibernated or aestivated states) suggesting a 
dependence on behavioral state of the animal.  
In a WB study a 14 kDa protein band was detected by PACAP-27 (n° 92112-4 antibody), and 
PACAP-38 antibodies (n° 88111-3). In addition, the anti-PACAP-38 reacted with a protein at 
4.5 kDa. It is speculated that data obtained by both antibodies at 14 kDa represents an 
extended PACAP-like molluscan peptide or the precursor form of PACAP. In human prostate 
and prostate cancer cells a 14.6 kDa product was described, which is likely a product of the 
prePACAP protein (19.9 kDa), partially processed by convertases (47). The assumption that 
extended PACAP-like molecules may exist is not unique. For example, in lower vertebrates, 
such as the stingray and catfish, 44 and 64 AA long PACAP molecules were observed (42, 
48). Using the MS/MS Fragment Ion Calculator the molecular weight based on sequence can 
be predicted accordingly, the average mass of protonated quasimolecular ion ([M
+
H]
+
) of 
stingray and catfish PACAP would be m/z 5338.25 (5.3 kDa) and m/z 7856.25 (7.8 kDa), 
respectively. Based on the MALDI TOF/TOF measurement similar sequences of PACAP-27 
and PACAP-38 can be identified from hemolymph and CNS samples of the snail with a 
molecular weight of 3147.1 and 4535.2, respectively. In addition, fragments of a PACAP-like 
molecule were found in Helix CNS homogenate with an identical AA sequence to mammalian 
PACAP-27 and -38 at positions 1-10 and 20-27 (16). The AA sequence at 27-38 differs by 
only one AA, (an iso-leucine to valin substitution) according to the mass calculation. Mass 
spectra of tryptic digest obtained by MALDI-TOF MS from Lymnaea CNS homogenate 
revealed complete sequence similarity of fragments between 1-32 AAs compared to 
mammalian PACAP-38 (45). The average mass of [M
+
H]
+
 of synthetic mammalian PACAP-
38 is m/z 4535.47 while in the pond snail, squid, planarian and hydra the hypothetical average 
[M
+
H]
+
 of the PACAP-38-like molecule is m/z 4656.37. The reason for this difference could 
be the discrepancy in three AAs between synthetic mammalian PACAP-38 and isolated 
invertebrate PACAP-38-like molecule (49).  
The PAC1-like receptor was also identified in the snail by IHC and biochemical methods (16, 
45). Similarly to vertebrate, PACAP activates a G-protein coupled receptor and acts through 
the AC-cAMP pathway (45, 50). In Lymnaea cerebral ganglia, the synthetic PACAP-38 
incubation increased cAMP level by 82%. In addition, both maxadilan, a specific PAC1-R 
agonist (51), and VIP, an agonist of VPAC1 and VPAC2 receptors also binding PACAP (19), 
increased cAMP synthesis by 47% and 79%, respectively. About 50% of the cAMP-
stimulating effect of PACAP-38 could be blocked by co-application of PACAP6-38 or 
maxadilan antagonist (M65). The biochemical results confirmed that PACAP-like peptides 
could increase cAMP levels through PACAP receptors in CNS or PNS. PAC1-like receptor 
expressing neuronal elements were observed in the CNS and a number of peripheral organs 
such as columellar muscle, heart, tentacles and epithelial glandular cells. Far-WB experiments 
revealed three binding sites in snail brain homogenate. Two of these corresponded well to the 
VPAC1 (~45 kDa) and PAC1 (~60 kDA) receptors of vertebrates (16).  
 Insects 
Using a vertebrate PACAP-38 antiserum (RIN-8920, Peninsula, CA, USA) PACAP-38-1ike 
IR was found in a subset of larval CNS neurons of Drosophila (37). Furthermore, PACAP38-
1ike IR was also found in nerve terminals innervating almost all muscle fibers in wild type 
and NF1 mutant larvae (37, 52). The staining appeared to be concentrated in varicosities 
where synaptic vesicles are localized. A comparison of the patterns of IR with previous anti-
horseradish peroxidase staining, which reveals all nerve terminals arborized on muscle fibers, 
suggests that PACAP38-1ike IR is restricted to large-sized type varicosities typical for 
neuropeptides.  
In contrast to Oligochaetes and Gastropods, only the PACAP-38 isoform was present in the 
CNS of Insects (37). In WB experiments an IR band was observed at 5.4 kDa that compared 
well with calculated mass of 4.5 kDa of mammalian PACAP-38. In addition a 19 kDa band 
was detected which may represent a possible PACAP precursor polypeptide in Drosophila. It 
is concluded that antibodies raised against mammalian PACAP38 identifies an insect 
polypeptide with similar size (37).  
In Drosophila a neuropeptide gene was identified that has some identity to PACAP (38). This 
gene, named amnesiac, encodes a signal peptide followed by several possible peptides 
depending on the cleavage sites. One of the peptides deduced from the gene had 10% identity 
with human PACAP-38 or 18% with PACAP-27. This identity is too low to claim that 
amnesiac is homologous to PACAP in tunicates or vertebrates. However, the authors showed 
that an inserted space in PACAP after both amino acids 23 and 27 would increase the identity 
to 21% for PACAP-38 and 30% for PACAP-27. If amino acid similarity is used for the 
calculation, the relationship is higher (35).  
 
Malacostraca 
In some protostomes, such as the planarian (Dugesia japonica), the american cockroach 
(Periplaneta americana) and the bigfin reef squid (Sepioteuthis lessoniana) partial mRNAs 
corresponding to the highly conserved PACAP coding exon have been deposited in public 
databases (53). Based on this public sequence information, Lugo and his coworkers (54) 
proposed a degenerative primer pair (F-LvPACAP and R-LvPACAP) and isolated for the first 
time the cDNA encoding the mature PACAP molecule from neural eyestalk tissue of a 
crustacean species, the white shrimp (Litopenaeus vannamei) by RT-PCR. Its high degree of 
sequence conservation is corroborated, when compared with sequences reported from 
tunicates (Chelyosoma productum) to mammalian vertebrates.  
 
Functions of PACAP 
The eukaryote Tetrahymena thermophila is a free-living ciliate protozoon widely used as an 
animal model in biological and biomedical research and exhibits a behavioural avoidance to 
PACAP-38. For example, the antagonists PACAP6-27 and 6-38, which inhibit PACAP 
receptors, serve as agonists for Tetrahymena (55). The possibility cannot be excluded that 
PACAP is able to exert its action by directly activating the AC-cAMP pathways penetrating 
the cell membrane. 
The high structural conservation and interphyletic distribution of a PACAP-like peptide and 
its receptor molecules suggest that this peptide is involved in the regulation of several basic 
physiological functions in invertebrates similar to those observed in vertebrates.  
 
Effect in regeneration  
PACAP is involved in an array of physiological functions, thus, the role of the peptide is 
thought to be essential for cell survival. This is supported by the observation that the mortality 
of PACAP or PACAP receptor knockout mice is much higher than their wild type mates (4, 
19, 35, 56, 57). Studies in PACAP knockout animals provide further evidence for the 
involvement of endogenous PACAP in regeneration processes. Upregulation of PACAP 
following nervous injuries has been shown in vertebrates by numerous previous studies (58). 
It has been shown by RIA and IHC methods that the concentration of PACAP-like 
compounds increase in regenerating CNS and peripheral tissues of the earthworm Eisenia 
following injury indicating the possible role of PACAP in the regeneration (40). Significant 
increase in the concentration of PACAP-like compounds was also observed in coelomocytes 
of regenerating earthworm (59). Electron microscopic immunocytochemistry showed that 
PAC1 receptors are located on coelomocytes (mainly on amebocytes and on some 
granulocytes). Authors hypothesize a link between PACAP and coelomocytes, suggesting that 
PACAP modulates the function of amebocytes and certain granulocytes that play a role in 
regenerating earthworms. The data show that PACAP-like peptide(s) accumulate in the 
regenerating tissues of the earthworm suggesting trophic functions of these compounds in 
invertebrate tissues similarly to that observed on vertebrates. 
Anti-apoptotic effect 
The anti-apoptotic effect of PACAP on vertebrate neuronal and non-neuronal cells is well 
documented (6, 7, 60, 61). The anti-apoptotic effect of PACAP is mainly mediated by PAC1 
receptor. The results imply that the anti-apoptotic effect of PACAP may be one of the basic 
functions of the peptide through evolution; both the peptide structure and this function have 
been conserved. PACAP has anti-apoptotic effect in the salivary gland cells of the snail (8). In 
several Gastropod species saliva or mucus release is performed by the holocrine release 
mechanism leading to cell destruction (62). It has been suggested that cell death is indeed the 
physiological method of saliva release which takes place through a form of programmed cell 
death that is regulated by transmitters. It has been observed that stimulation of the salivary 
nerve or external application of dopamine elicits a change of mitochondrial membrane 
potential, and translocation of cytochrome-c from mitochondria to the cytoplasm typical for 
the intrinsic mitochondrial pathway of programmed cell death. It has been observed that 
PACAP significantly attenuates the dopamine- and colchicine–induced apoptosis (8, 63).  
Effect on ion channels  
In snail (Helix) neurons expressing PAC1-like receptors synthetic PACAP-27 and -38 elicited 
membrane potential changes (both hyper- and depolarisation) leading to significant changes in 
action potential frequency. PACAP6-38, as a receptor antagonist, powerfully antagonized the 
membrane effect of PACAP (16). These results may suggest that PACAP is able to modulate 
the ion channels responsible for membrane and action potential generation. PACAP-like 
peptide has been found to modulate ionic conductance at the neuromuscular junction (37, 64): 
in Drosophila larval muscles synthetic PACAP-38 enhanced L-type Ca
2+
-current via AC-
cAMP-PKA pathway (64). Focal application of vertebrate PACAP-38 to the neuromuscular 
junction of Drosophila larval muscle triggered two temporally distinct responses: an 
immediate depolarization and a large enhancement of K-current. The enhancement occurred 
12-14 minutes after the early depolarization. The effect of external PACAP-38 could be 
mimicked by high frequency stimulation of motor nerve suggesting that PACAP or PACAP-
like peptide is co-released and is functionally present in nerve terminals (37). In the tentacle 
flexor muscles of the land snail, Helix, a potentiating effect of synthetic PACAP-27 was 
observed on cholinergic neuromuscular transmission. PACAP-27 presynaptically enhanced 
the release of acetylcholine by activating the AC-cAMP-PKA pathway. Postsynaptically, 
PACAP-27 enhanced muscle contractility by PKC-mediated signaling pathway resulting in an 
increased Ca
2+ 
release from intracellular stores. These findings suggest that regulation of Ca
2+ 
release may contribute to the stimulatory effect of PACAP (9). 
 
Role of PACAP in learning and memory 
PACAP activates molecular cascades leading to the execution of many physiological 
processes, including learning and memory (50, 65). Feany and Quinn (38), cloning the 
memory gene in Drosophila responsible for the amnesiac mutation, observed that one of the 
“amnesiac” potential neuropeptide (AMN) had homology to the gene that encodes 
mammalian PACAP. The amn gene encodes a homolog of vertebrate PACAP, the AMN, 
strongly expressed in dorsal paired medial (DPM) neurons which is required for stable 
memory (66). Furthermore, DMP activity is needed for middle-term memory so suggesting 
that the PACAP-like AMN peptide release from the DPM neurons contributes to memory 
persistence (11, 66, 67). 
The Lymnaea homologue of PACAP was found necessary for the aquisition and consolidation 
of long-term memory in the snail. We showed that systemic application of synthetic PACAP-
27 or -38 accelerated the formation of transcription-dependent memory during single trial 
reward chemical or multiple aversive tactile conditioning in Lymnaea. Using the antagonist 
PACAP6-38 it was also shown that the memory accelerating effect of PACAP depended on 
G-protein coupled PAC1-like receptors (50).  
The age-related decline in memory performance could be reversed by administration of 
PACAP. Exogenous PACAP-38 boosted memory formation in aged Lymnaea, where 
endogenous PACAP-38 levels were significantly lower than in young snail based on WB 
experiments. In aged Lymnaea, there was a significant deficit of both intermediate- and long 
term memory formation after one-trial reward conditioning. The deficit in both of these types 
of memory, however, was rescued by the application of the synthetic PACAP-38 peptide 
before training. Due to the evolutionarily conserved nature of these polypeptides and their 
established role in memory and synaptic plasticity, there was a very high probability that they 
could also act as “memory rejuvenating” agents (68). 
The role of PACAP and/or PACAP-like peptide(s) in acquisition and memory consolidation 
and recall in invertebrate model animals is discussed in detail in another chapter (I. Kemenes 
and G. Kemenes). 
 
Summary 
The primary structure of PACAP has proved to be remarkably conserved during evolution not 
only in higher and lower vertebrates but also in invertebrates. In Table 1 different sequences 
of invertebrate PACAP molecules are aligned with human PACAP using ClustalW2 - 
Multiple Sequence Alignment. Detailed analysis revealed a high homology (>89 %) of 
inferred amino acid sequences: 35 AAs are conserved at the N-terminus and 3 AAs are 
variable at the C-terminus. Unfortunately, there is currently no definite sequence information 
about invertebrate PACAP or PACAP-like molecule(s) (3, 4, 69, 70). Therefore, in IHC 
experiments different types of vertebrate antibodies are used which raises questions about the 
authenticity of the reported data even though antibodies with different epitopes produce the 
same effect. In WB experiments applying the same vertebrate antibodies the masses of 
immunopositive WB bands differ from that of expected. On the contrary, in most of the 
physiological experiments powerful and clear effect of the externally applied PACAP is 
observed suggesting the presence of specific receptor able to recognize synthetic PACAP. 
Although partial cDNA encoding PACAP-like peptide(s) in protostomes has been reported, 
no cDNA or gene encoding a PACAP-like peptide has been identified so far in species with 
fully/partially sequenced genomes  (19, 53). However, a highly conserved partial sequence 
corresponding to the exon encoding the mature PACAP peptide has been isolated in Hydra 
magnipapillata, in the tunicate, Halocynthia roretzi and in several protostomes such as 
planarian (Dugesia japonica), crab (Eriocheir japonica), squid (Sepioteuthis lessoniana) and 
cockroach (Periplaneta americana). 
In conclusion, PACAP or PACAP-like peptide(s) is present in invertebrates but the existence 
of a PACAP gene or peptide homologue remains to be convincingly demonstrated. However, 
the reported physiological effects of PACAP further confirm the presence of PACAP(-like) 
signaling pathways in invertebrates. 
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